A service of StreetInsider.com
Welcome

Most Popular

AAPL 222.25
C 3.90
GOOG 560.00
BAC 16.82
RIMM 73.06

Recently Added

WWIN 6.46
CCLTF 9.20
KCAP 5.51
NWM 0.01
CNYD 13.05

Gaining Speed

CNYD 13.05
KCAP 5.51
CCLTF 9.20
AGHD 0.00
HYII 0.00
26.01 -0.06 (-0.23%) BMY

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:26.01 Change:-0.06 (-0.23%) Prev Close:26.07 Open: 26.13 Days Range:25.86 – 26.25 52 Week Range: 18.83 - 26.62 Volume:14936023 P/E: 15.96
EPS:1.63

Member Comments

No member comments available for BMY


Not logged in - Log in or Sign up to leave comments





View AllRecent Alerts 03/21/10

Recent Alert on 03/17/10 at 9:07am
Bristol-Myers (BMY), AstraZeneca (AZN) Announce FDA Acceptance of NDA for Combination of ONGLYZA and ER Metformin

Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. FDA has accepted for review a New Drug Application for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4... Read More

Recent Alert on 03/17/10 at 9:07am
Bristol-Myers (BMY), AstraZeneca (AZN) Announce FDA Acceptance of NDA for Combination of ONGLYZA and ER Metformin
Recent Alert on 03/12/10 at 1:12pm
Sanofi-aventis (SNY) and Bristol-Myers Squibb (BMY) Update on PLAVIX Revisions
Recent Alert on 03/12/10 at 1:12pm
Sanofi-aventis (SNY) and Bristol-Myers Squibb (BMY) Update on PLAVIX Revisions
Recent Alert on 03/12/10 at 7:31am
Jefferies & Co Initiates Coverage on Big Pharma Stocks LLY & BMY

View AllRecent Press Releases

Press Release on 03/17/10 at 9:00am
U.S. Food And Drug Administration Accepts New Drug Application For Once-Daily Fixed Dose Combination Of Onglyza(TM) (Saxagliptin) And Extended Release Metformin For The Treatment Of Type 2 Diabetes Me

View AllRecent SEC Filings

SEC Filing on 03/18/10 at 4:13pm
Form 4 BRISTOL MYERS SQUIBB CO For: Mar 03 Filed by: Caldarella Joseph C
SEC Filing on 03/18/10 at 9:32am
Form 4 BRISTOL MYERS SQUIBB CO For: Mar 17 Filed by: DANIELS BRIAN
SEC Filing on 03/17/10 at 12:26pm
Form 4 BRISTOL MYERS SQUIBB CO For: Mar 12 Filed by: Cazala Beatrice J
SEC Filing on 03/17/10 at 12:26pm
Form 4 BRISTOL MYERS SQUIBB CO For: Mar 15 Filed by: SIGAL ELLIOT

View AllRecent Blog Posts

Blog Posts on 03/18/10 at 4:55pm
Boost for Bristol Myers
Blog Posts on 03/14/10 at 7:41am
Abbott Buys Facet to Strengthen Biologics Capabilities, Pharma Pipeline
Blog Posts on 03/12/10 at 11:10am
Analyst Calls: ABT, ARO, BMY, CELG, DNDN, FACT, GS, PSUN, SCCO, ULTI ...
Blog Posts on 03/08/10 at 8:51am
Why Hedge Funds Like Mead Johnson Nutrition
Blog Posts on 03/03/10 at 7:19am
Wall Street Breakfast: Must-Know News